Breaking News Instant updates and real-time market news.

AGIO

Agios Pharmaceuticals

$50.20 /

+0.96 (+1.95%)

, ASND

Ascendis Pharma

$138.87 /

+0.04 (+0.03%)

04:55
01/16/20
01/16
04:55
01/16/20
04:55

JPMorgan to hold a conference

38th Annual Healthcare Conference will be held in San Francisco on January 13-16.

AGIO

Agios Pharmaceuticals

$50.20 /

+0.96 (+1.95%)

ASND

Ascendis Pharma

$138.87 /

+0.04 (+0.03%)

TDOC

Teladoc

$93.94 /

-2.935 (-3.03%)

GILD

Gilead

$64.11 /

-0.11 (-0.17%)

NVCR

Novocure

$84.37 /

+1.96 (+2.38%)

JAZZ

Jazz Pharmaceuticals

$152.80 /

+2.79 (+1.86%)

TEVA

Teva

$10.56 /

+0.51 (+5.07%)

PGNY

Progyny

$31.02 /

-2.315 (-6.95%)

VRTX

Vertex

$234.03 /

+4.24 (+1.85%)

HCAT

Health Catalyst

$36.14 /

+0.78 (+2.21%)

UTHR

United Therapeutics

$92.46 /

+0.67 (+0.73%)

JNJ

Johnson & Johnson

$146.97 /

+0.39 (+0.27%)

WELL

Welltower

$84.99 /

+0.96 (+1.14%)

VIR

Vir Biotechnology

$15.28 /

+0.77 (+5.31%)

TFX

Teleflex

$380.15 /

-2.975 (-0.78%)

RGEN

Repligen

$99.66 /

+0.2 (+0.20%)

REPL

Replimune Group

$18.27 /

+0.29 (+1.61%)

RIGL

Rigel Pharmaceuticals

$2.73 /

+0.115 (+4.40%)

NVRO

Nevro

$118.14 /

+3.805 (+3.33%)

OYST

Oyster Point Pharma

$25.56 /

-1.25 (-4.66%)

NVO

Novo Nordisk

$62.39 /

+2.77 (+4.65%)

MYOK

MyoKardia

$75.97 /

-0.78 (-1.02%)

MOH

Molina Healthcare

$139.00 /

+7.15 (+5.42%)

LH

LabCorp

$178.20 /

-2.13 (-1.18%)

LLY

Eli Lilly

$141.09 /

+0.45 (+0.32%)

LMNX

Luminex

$23.49 /

-0.1 (-0.42%)

ILMN

Illumina

$320.48 /

+3.38 (+1.07%)

ITCI

Intra-Cellular

$26.31 /

-0.49 (-1.83%)

HOLX

Hologic

$53.75 /

+0.26 (+0.49%)

IDYA

Ideaya Biosciences

$10.96 /

+0.52 (+4.98%)

FOLD

Amicus

$10.40 /

+0.54 (+5.48%)

EBS

Emergent BioSolutions

$54.92 /

-0.11 (-0.20%)

CTLT

Catalent

$60.85 /

+0.51 (+0.85%)

  • 16

    Jan

  • 22

    Jan

  • 22

    Jan

  • 25

    Jan

  • 27

    Jan

  • 29

    Jan

  • 29

    Jan

  • 29

    Jan

  • 29

    Jan

  • 30

    Jan

  • 03

    Feb

  • 10

    Feb

  • 10

    Feb

  • 11

    Feb

  • 12

    Feb

  • 13

    Feb

  • 24

    Feb

  • 27

    Feb

  • 09

    Mar

  • 17

    Mar

  • 19

    Mar

  • 27

    Apr

AGIO Agios Pharmaceuticals
$50.20 /

+0.96 (+1.95%)

12/09/19 CANT
Cantor sees Agios trading up 5%-10% on mitapivat update
12/11/19 PIPR
Agios Pharmaceuticals remains a favorite name at Piper Jaffray
12/17/19 PIPR
Agios Pharmaceuticals shares should be owned through 2020, says Piper Jaffray
01/02/20 GUGG
Incyte downgraded to Neutral after strong 2019 at Guggenheim
ASND Ascendis Pharma
$138.87 /

+0.04 (+0.03%)

10/29/19 ADAM
Ascendis Pharma well positioned into new year, says Canaccord
11/18/19 JPMS
Ascendis Pharma weakness related to CMO exit, says JPMorgan
12/03/19 LEER
Ascendis Pharma price target raised to $152 from $140 at SVB Leerink
12/18/19 JPMS
BioMarin, Vertex among JPMorgan's top Biotech picks for 2020
TDOC Teladoc
$93.94 /

-2.935 (-3.03%)

01/13/20 ADAM
Teladoc enters hospital market in big way with acquisition, says Canaccord
01/14/20 KEYB
Teladoc price target raised to $106 from $93 at KeyBanc
01/14/20 LEHM
Teladoc price target raised to $95 from $80 at Barclays
01/14/20 GUGG
Teladoc price target raised to $110 from $90 at Guggenheim
GILD Gilead
$64.11 /

-0.11 (-0.17%)

12/13/19 FBCO
Gilead downgraded to Underperform from Neutral at Credit Suisse
12/13/19
Fly Intel: Top five analyst downgrades
01/02/20 PIPR
Gilead HIV drug price hikes 'appear reasonable,' says Piper Jaffray
NVCR Novocure
$84.37 /

+1.96 (+2.38%)

09/13/19 OPCO
Novocure price target raised to $97 from $85 at Oppenheimer
12/12/19 WELS
Novocure price target raised to $85 from $75 at Wells Fargo
01/02/20 EVER
Novocure downgraded to In Line from Outperform at Evercore ISI
01/07/20 MZHO
Novocure recent share weakness a buying opportunity, says Mizuho
JAZZ Jazz Pharmaceuticals
$152.80 /

+2.79 (+1.86%)

12/03/19 WELS
Jazz Pharmaceuticals price target raised to $186 from $168 at Wells Fargo
12/05/19 JPMS
Jazz Pharmaceuticals shares offer attractive entry point, says JPMorgan
12/18/19 JMPS
JMP reiterates Outperform on Pfenex after Jazz milestone payment
01/08/20 GSCO
Jazz Pharmaceuticals initiated with a Neutral at Goldman Sachs
TEVA Teva
$10.56 /

+0.51 (+5.07%)

11/12/19
Fly Intel: Top five analyst upgrades
11/18/19 OPCO
Teva may be positioned to sustain U.S. generic revenue base, says Oppenheimer
11/20/19 JEFF
Teva 'offered little' on progress toward opioids settlement, says Jefferies
11/27/19 GABE
Teva shares should be bought on opioid suit headline weakness, says Gabelli
PGNY Progyny
$31.02 /

-2.315 (-6.95%)

11/19/19 PIPR
Progyny initiated with an Overweight at Piper Jaffray
11/19/19 LEER
Progyny initiated with an Outperform at SVB Leerink
11/19/19 SBSH
Progyny initiated with a Buy at Citi
11/19/19 JPMS
Progyny initiated with an Overweight at JPMorgan
VRTX Vertex
$234.03 /

+4.24 (+1.85%)

01/06/20 PIPR
Vertex price target raised to $284 from $247 at Piper Sandler
01/08/20 SBSH
Citi ups Vertex price trarget to $265, calls a top pick for 2020
01/08/20 OPCO
Vertex price target raised to $265 from $230 at Oppenheimer
01/09/20 BMOC
Vertex price target raised to $268 from $248 at BMO Capital
HCAT Health Catalyst
$36.14 /

+0.78 (+2.21%)

10/29/19 CANT
Health Catalyst initiated with an Overweight at Cantor Fitzgerald
10/30/19
Fly Intel: Top analyst initiations
12/19/19 RAJA
Health Catalyst initiated with a Strong Buy at Raymond James
12/19/19 RAJA
Health Catalyst initiated with a Strong Buy at Raymond James
UTHR United Therapeutics
$92.46 /

+0.67 (+0.73%)

08/01/19
Fly Intel: Top five analyst upgrades
12/03/19 BOFA
United Therapeutics initiated with an Underperform at BofA/Merrill
12/27/19 OPCO
Oppenheimer sees 'unloved' United Therapeutics being set up well for 2020
JNJ Johnson & Johnson
$146.97 /

+0.39 (+0.27%)

12/30/19 HCWC
J&J declining option with Provention for PRV-6527 expected, says H.C. Wainwright
01/09/20 WELS
Johnson & Johnson price target raised to $165 from $155 at Wells Fargo
01/09/20 JMPS
Argenx price target raised to $170 from $164 at JMP Securities
01/10/20 BWSF
Anika acquisitions set up direct competition with partner, says BWS Financial
WELL Welltower
$84.99 /

+0.96 (+1.14%)

12/18/19 JPMS
JPMorgan makes 17 REIT rating changes in conjunction with 2020 outlook
12/19/19 MZHO
Welltower initiated with a Buy at Mizuho
01/06/20 EVER
Welltower upgraded to Outperform from In Line at Evercore ISI
01/07/20 RAJA
Healthcare REIT sector downgraded to Market Weight at Raymond James
VIR Vir Biotechnology
$15.28 /

+0.77 (+5.31%)

11/05/19 LEHM
Vir Biotechnology initiated with an Overweight at Barclays
11/05/19 JPMS
Vir Biotechnology initiated with an Overweight at JPMorgan
11/13/19 BARD
Vir Biotechnology initiated with a Neutral at Baird
11/14/19
Fly Intel: Top five analyst initiations
TFX Teleflex
$380.15 /

-2.975 (-0.78%)

08/05/19 JMPS
Teleflex price target raised to $395 from $325 at JMP Securities
08/05/19 JMPS
Teleflex price target raised to $395 from $325 at JMP Securities
10/31/19 PIPR
Urolift driving majority of Teleflex earnings beat, says Piper Jaffray
12/12/19 WELS
SeaSpine, Glaukos double-downgraded to Underweight at Wells Fargo
RGEN Repligen
$99.66 /

+0.2 (+0.20%)

08/28/19 FANA
Repligen price target raised to $107 from $95 at First Analysis
10/15/19 LEER
Repligen initiated with an Outperform at SVB Leerink
11/01/19 FANA
Repligen upgraded to Strong Buy from Outperform at First Analysis
11/14/19 STFL
Repligen initiated with a Buy at Stifel
REPL Replimune Group
$18.27 /

+0.29 (+1.61%)

07/23/19 CHDN
Replimune Group initiated with a Buy at Chardan
08/06/19 WEDB
Replimune Group, Sallie Mae removed from Best Ideas List at Wedbush
09/04/19 ROTH
Replimune Group initiated with a Buy at Roth Capital
11/11/19 ROTH
Replimune Group price target raised to $30 from $20 at Roth Capital
RIGL Rigel Pharmaceuticals
$2.73 /

+0.115 (+4.40%)

09/26/19
Fly Intel: Top five analyst initiations
11/15/19 CANT
Rigel Pharmaceuticals assumed with an Overweight at Cantor Fitzgerald
11/15/19
Fly Intel: Top five analyst initiations
01/13/20 PIPR
Rigel still one of the most under-appreciated stories in sector, says Piper
NVRO Nevro
$118.14 /

+3.805 (+3.33%)

11/07/19 OPCO
Nevro upgraded to Outperform with $106 price target at Oppenheimer
01/06/20 OPCO
Nevro downgraded to Perform from Outperform at Oppenheimer
01/06/20 OPCO
Oppenheimer downgrades Nevro with optimistic outlook already baked in
01/07/20 RHCO
Nevro initiated with a Buy at SunTrust
OYST Oyster Point Pharma
$25.56 /

-1.25 (-4.66%)

11/25/19 PIPR
Oyster Point Pharma initiated with an Overweight at Piper Jaffray
11/25/19 COWN
Oyster Point Pharma initiated with an Outperform at Cowen
11/25/19 JPMS
Oyster Point Pharma initiated with an Overweight at JPMorgan
01/13/20 PIPR
Oyster Point data show 'robust and durable' effect, says Piper Sandler
NVO Novo Nordisk
$62.39 /

+2.77 (+4.65%)

11/19/19 RHCO
Dicerna price target raised to $28 from $24 at SunTrust
11/22/19 PART
Novo Nordisk downgraded to Hold from Buy at Pareto
01/03/20 GUGG
Novo Nordisk downgraded to Neutral from Buy at Guggenheim
01/03/20 GUGG
Novo Nordisk downgraded to Neutral on continued insulin headwinds at Guggenheim
MYOK MyoKardia
$75.97 /

-0.78 (-1.02%)

09/19/19 GUGG
Zealand Pharma initiated with a Buy at Guggenheim
09/20/19
Fly Intel: Top five analyst initiations
12/20/19 SBSH
Citi ups MyoKardia target to $87 from $70, calls a top pick for 2020
MOH Molina Healthcare
$139.00 /

+7.15 (+5.42%)

12/19/19 JPMS
ACA ruling removes partial overhang on Centene and Molina, says JPMorgan
12/20/19 JPMS
JPMorgan reverses stance on Managed Care, turns more bullish into 2020
12/24/19 SPHN
Kentucky Medicaid rebidding news a disappointment for Molina, says Stephens
01/07/20 DBAB
Molina Healthcare price target raised to $150 from $145 at Deutsche Bank
LH LabCorp
$178.20 /

-2.13 (-1.18%)

09/16/19
LabCorp management to meet with SunTrust
12/19/19 JPMS
JPMorgan calls CVS top sector pick for 2020, boosts price target to $97
01/07/20 WELS
LabCorp initiated with an Overweight at Wells Fargo
01/07/20 WELS
Wells Fargo initiates Life Science Tools, Services, Diagnostics Sector
LLY Eli Lilly
$141.09 /

+0.45 (+0.32%)

12/20/19 STFL
Stifel says Lexicon 'missed opportunity' with sotagliflozin data
12/30/19 ARGS
Eli Lilly price target raised to $165 from $145 at Argus
01/08/20 PIPR
Eli Lilly still has edge over Blueprint in RET+ lung cancer, says Piper Sandler
01/13/20 PIPR
Partnership termination not a negative for NextCure N318, says Piper Sandler
LMNX Luminex
$23.49 /

-0.1 (-0.42%)

09/27/19 JPMS
Luminex downgraded to Underweight from Neutral at JPMorgan
09/27/19 JPMS
JPMorgan downgrades Luminex to Underweight, cuts price target to $21
11/11/19 BTIG
Luminex price target lowered to $32 from $37 at BTIG
ILMN Illumina
$320.48 /

+3.38 (+1.07%)

01/07/20 WELS
Illumina initiated with an Underweight at Wells Fargo
01/09/20 PIPR
Illumina price target raised to $370 from $341 at Piper Sandler
01/13/20 WELS
Wells says Illumina's below consensus guidance not necessarily conservative
ITCI Intra-Cellular
$26.31 /

-0.49 (-1.83%)

09/10/19 JMPS
JMP Securities sees 'successful' review of Intra-Cellular lumateperone NDA
12/23/19 STFL
Stifel sees Intra-Cellular's Lumateperone approval as bullish for CNS stocks
12/23/19 BTIG
Intra-Cellular price target raised to $73 from $34 at BTIG
12/23/19 ADAM
Intra-Cellular price target raised to $65 from $29 at Canaccord
HOLX Hologic
$53.75 /

+0.26 (+0.49%)

11/20/19 PIPR
Hologic sale of Cynosure the right move, says Piper Jaffray
01/02/20 EVER
Hologic downgraded to In Line from Outperform at Evercore ISI
01/06/20 SBSH
Hologic initiated with a Buy at Citi
01/07/20 WELS
Hologic initiated with an Equal Weight at Wells Fargo
IDYA Ideaya Biosciences
$10.96 /

+0.52 (+4.98%)

06/17/19 JEFF
Ideaya Biosciences initiated with a Buy at Jefferies
09/09/19 BARD
Ideaya Biosciences initiated with an Outperform at Baird
09/10/19 BARD
Ideaya Biosciences coverage initiated, disruptive for uveal melanoma says Baird
10/17/19 OPCO
Ideaya Biosciences initiated with an Outperform at Oppenheimer
FOLD Amicus
$10.40 /

+0.54 (+5.48%)

06/17/19 HCWC
Amicus initiated with a Buy at H.C. Wainwright
06/17/19
Fly Intel: Top five analyst initiations
10/03/19 COWN
Amicus weakness a buying opportunity, says Cowen
10/14/19 HCWC
Amicus recent selloff brings 'compelling opportunity,' says H.C. Wainwright
EBS Emergent BioSolutions
$54.92 /

-0.11 (-0.20%)

09/04/19 WELS
Wells Fargo upgrades Emergent BioSolutions after 'major' contact win
09/11/19 GUGG
Emergent BioSolutions initiated with a Buy at Guggenheim
11/22/19 CANT
Cantor reiterates Overweight on Emergent BioSolutions with $75 price target
01/08/20 GUGG
Horizon Therapeutics named Guggenheim's best Emerging Pharma idea for 2020
CTLT Catalent
$60.85 /

+0.51 (+0.85%)

08/28/19
Catalent downgraded to Sector Weight on valuation at KeyBanc
08/28/19 BARD
Catalent price target raised to $60 from $50 at Baird
08/28/19
Fly Intel: Top five analyst downgrades
10/17/19 SPHN
Catalent resumed with an Overweight at Stephens

TODAY'S FREE FLY STORIES

General news
FX Action: USD-CAD has consolidated in the lower 1.3100s » 03:50
01/24/20
01/24
03:50
01/24/20
03:50

FX Action: USD-CAD has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
FX Update: Narrow ranges have been seen » 03:25
01/24/20
01/24
03:25
01/24/20
03:25

FX Update: Narrow ranges…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
FX Update: Narrow ranges have been seen » 03:15
01/24/20
01/24
03:15
01/24/20
03:15

FX Update: Narrow ranges…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Asian Market Update: » 01:50
01/24/20
01/24
01:50
01/24/20
01:50

Asian Market Update:…

Asian Market Update: Treasury yields are up 0.7 bp at 1.739% as Asian stock markets stabilised. Wall Street managed to claw back early losses to close little changed on Thursday and sentiment in Asia also improved somewhat, with most indices moving slightly higher, despite the spreading of the Wuhan coronavirus. Up to 10 cities across China are now reported to be in lockdown and the death-toll is rising. The number of cases outside of China is also rising although the WHO stepped short of declaring a Public Health Emergency of International Concern (PHEIC) yesterday, which helped to calm nerves. Mainland China bourses are now closed for the Lunar New Year holiday's, but the Hang Seng managed to move up 0.15%. Topix and Nikkei are down -0.06% and up 0.13% respectively and the ASX lifted 0.04%. U.S. futures are posting gains of around 0.1-0.2%. On the data front Japan core CPI came in a tad higher than expected and lifted to 0.7% from 0.5%, but this is still far below target. Australia PMI readings signaled continued decline in business activity, but after the strong employment report this week Westpac still dropped its rate cut forecast for February. USD-JPY is little changed at 109.53 and the front end WTI future is trading at USD 55.83 per barrel.

Syndicate
Applied Therapeutics 2.74M share Secondary priced at $45.50 » 23:52
01/23/20
01/23
23:52
01/23/20
23:52
APLT

Applied Therapeutics

$48.96 /

+0.6 (+1.24%)

The deal size was…

The deal size was increased from 1.75M shares and priced below the last close price of $48.85. Goldman Sachs, Cowen and UBS are acting as joint book running managers for the offering.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24
    Jan
Syndicate
Adaptive Biotechnologies 8M share Secondary priced at $26.50 » 23:50
01/23/20
01/23
23:50
01/23/20
23:50
ADPT

Adaptive Biotechnologies

$26.86 /

-0.34 (-1.25%)

JPMorgan, Goldman Sachs,…

JPMorgan, Goldman Sachs, BofA, Cowen, Guggenheim and William Blair are acting as joint book running managers for the offering.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24
    Jan
Hot Stocks
Pacific City Financial raises quarterly dividend to 10c from 8c per share » 20:43
01/23/20
01/23
20:43
01/23/20
20:43
PCB

Pacific City Financial

$15.41 /

+0.09 (+0.59%)

The dividend will be paid…

The dividend will be paid on or about March 13, 2020, to shareholders of record as of the close of business on February 28, 2020.

Earnings
Notable companies reporting before tomorrow's open » 20:25
01/23/20
01/23
20:25
01/23/20
20:25
AXP

American Express

$131.40 /

-0.16 (-0.12%)

, NEE

NextEra Energy

$260.00 /

+0.15 (+0.06%)

, SYF

Synchrony

$36.19 /

-0.23 (-0.63%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include NextEra Energy (NEE), consensus $1.50... American Express (AXP), consensus $2.01... Synchrony (SYF), consensus $1.07.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Trump to sign USMCA trade deal on Wednesday, Reuters says » 20:11
01/23/20
01/23
20:11
01/23/20
20:11
SPY

SPDR S&P 500 ETF Trust

$331.81 /

+0.41 (+0.12%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

President Donald Trump…

President Donald Trump will sign the U.S.-Mexico-Canada Agreement on trade in a White House ceremony next Wednesday, Reuters' Jeff Mason writes, citing a source with the administration. The official calls the agreement a "major accomplishment" for the President after he pledged to overhaul NAFTA as a political candidate, Mason writes. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Investar Holding reports Q4 EPS 39c, consensus 48c » 19:36
01/23/20
01/23
19:36
01/23/20
19:36
ISTR

Investar Holding

$23.56 /

-0.48 (-2.00%)

Reports Q4 revenue…

Reports Q4 revenue $25.1M, consensus $18.88M. Reports Q4 net interest margin 3.44% vs. 3.53% last year. CEO John D'Angelo says: "Although we achieved a great deal during the quarter, our earnings were negatively impacted by additional provision expense of $0.2 million resulting from our strong loan growth which occurred late in the quarter, additional interest expense of $0.2 million on our $25.0 million subordinated debt, $0.2 million of legal expenses related to an acquired asset, $0.2 million of noninterest expense for our two new branches, and $0.3 million of additional expense for Louisiana Bank Shares Tax related to our growth."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Death toll related to China coronavirus has risen to 25 from 18, Bloomberg says  19:27
01/23/20
01/23
19:27
01/23/20
19:27
SPY

SPDR S&P 500 ETF Trust

$331.81 /

+0.41 (+0.12%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Turk Telekom upgraded to Buy from Neutral at Goldman Sachs » 19:11
01/23/20
01/23
19:11
01/23/20
19:11
TRKNY

Turk Telekom

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Vyacheslav Degtyarev upgraded Turk Telekom to Buy from Neutral with a price target of TRY 10.6, up from TRY 6.9. The analyst anticipates a gradual dividend restoration for the company in 2020 amid improved macro conditions, strengthened balance sheet, and "decent" profitability prospects.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Turk Telekom upgraded to Buy from Neutral at Goldman Sachs » 19:09
01/23/20
01/23
19:09
01/23/20
19:09
TRKNY

Turk Telekom

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Vyacheslav Degtyarev upgraded Turk Telekom to Buy and raised his price target to TRY10.6 from TRY6.9.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Heritage Commerce reports Q4 EPS 10c, consensus 24c » 19:06
01/23/20
01/23
19:06
01/23/20
19:06
HTBK

Heritage Commerce

$12.39 /

+0.01 (+0.08%)

"The fourth quarter…

"The fourth quarter of 2019 saw a significant accomplishment for Heritage Bank of Commerce with the completion of the Presidio Bank merger thereby creating the San Francisco Bay Area's premier community business bank with a strong depth of banking talent and an extensive and diverse customer base," said Keith A. Wilton, President and Chief Executive Officer. "Credit quality remains strong and the Bank continued to generate solid earnings for the fourth quarter and the full year of 2019, though these were partially reduced by anticipated merger-related costs from the Presidio merger."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Heritage Commerce increases quarterly dividend 8% to 13c per share » 19:05
01/23/20
01/23
19:05
01/23/20
19:05
HTBK

Heritage Commerce

$12.39 /

+0.01 (+0.08%)

Heritage Commerce Corp…

Heritage Commerce Corp announced that its Board of Directors increased its quarterly cash dividend 8% to $0.13 per share to holders of common stock. The dividend will be payable on February 19, 2020, to shareholders of record at close of business day on February 5, 2020.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Fly Intel: After Hours Movers » 18:43
01/23/20
01/23
18:43
01/23/20
18:43
EHTH

eHealth

$97.09 /

-2.51 (-2.52%)

, TEAM

Atlassian

$132.89 /

+1.52 (+1.16%)

, INTC

Intel

$63.32 /

+0.53 (+0.84%)

, NXGN

NextGen Healthcare

$15.93 /

+0.04 (+0.25%)

, SIVB

SVB Financial

$259.41 /

+2.86 (+1.11%)

, FLR

Fluor

$19.97 /

+0.115 (+0.58%)

, AVGO

Broadcom

$319.73 /

+6.81 (+2.18%)

, DFS

Discover

$85.77 /

+0.405 (+0.47%)

, ISRG

Intuitive Surgical

$614.64 /

+4.41 (+0.72%)

, SWKS

Skyworks

$128.18 /

+3.18 (+2.54%)

, BANR

Banner Corp.

$54.20 /

+0.34 (+0.63%)

, ETFC

E-Trade

$46.07 /

-0.44 (-0.95%)

, CVTI

Covenant Transportation

$12.88 /

-0.3 (-2.28%)

UP AFTER EARNINGS:…

UP AFTER EARNINGS: eHealth (EHTH) up 15.6%... Atlassian (TEAM) up 9.7%... Intel (INTC) up 5.2%... NextGen Healthcare (NXGN) up 3.6%... SVB Financial (SIVB) up 3.1%. ALSO HIGHER: Fluor (FLR) up 7.8% after its Stork JV was awarded engineering services contract for Dutch assets... Broadcom (AVGO) up 2.3% after announcing new component deal with Apple. DOWN AFTER EARNINGS: Discover (DFS) down 5.8%... Intuitive Surgical (ISRG) down 2.9%... Skyworks (SWKS) down 2.5%... Banner Corp (BANR) down 2.2%... E-Trade (ETFC) down 2.1%... Covenant Transport (CVTI ) down 1.6%. Movers as of 18:30ET.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
GrubHub CEO: We haven't had any offers » 18:39
01/23/20
01/23
18:39
01/23/20
18:39
GRUB

GrubHub

$57.76 /

+1.395 (+2.48%)

In an interview on…

In an interview on CNBC's Mad Money, GrubHub CEO Matt Maloney discussed a Wall Street Journal story from earlier this month which claimed the company was weighing a possible sale. Maloney said, "We haven't had any offers to buy the company," and added that he had "no idea" where the WSJ sourced its information. Maloney said GrubHub was "revolutionizing pick up" with its new Ultimate technology solution for restaurants. He noted that the product has been evolving for five years and the company is working on several stadium deals. Maloney said the company's "large loyalty infrastructure" will assist in the roll-out of the new platform.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Axel Springer plans to delist from Frankfurt Stock Exchange » 18:22
01/23/20
01/23
18:22
01/23/20
18:22
AXELF

Axel Springer

$0.00 /

+ (+0.00%)

, KKR

KKR

$31.20 /

-0.29 (-0.92%)

Axel Springer (AXELF)…

Axel Springer (AXELF) plans to withdraw from the stock exchange. A respective application will be made at the Frankfurt Stock Exchange prior to the expiration of the acceptance period of the delisting offer. The withdrawal from the regulated market of the Frankfurt Stock Exchange requires a public delisting offer to the Axel Springer SE shareholders as a precondition so that shareholders can sell their shares prior to the termination of the stock listing. According to an agreement signed today with Axel Springer SE, KKR (KKR) will make such an offer with an offer price amounting to EUR63 in cash per share. This payment is equal to the offer price for the previous public tender offer which was closed in December 2019. In 2019, Axel Springer and KKR entered into an investment agreement for a strategic partnership aimed at supporting the long-term growth strategy. Through a public tender offer as well as additional purchases, KKR has acquired approximately 44.9% of Axel Springer's share capital. In the public tender offer document of 5 July 2019 KKR has already announced its intention to propose a delisting to the other consortium members and to the Executive Board of Axel Springer SE following the successful tender offer.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
GrubHub launches 'Ultimate technology' for restaurants » 18:20
01/23/20
01/23
18:20
01/23/20
18:20
GRUB

GrubHub

$57.76 /

+1.395 (+2.48%)

Grubhub launched its…

Grubhub launched its Ultimate technology, "a revolutionary, first-of-its-kind proprietary hardware and software solution that integrates all restaurant ordering channels into one system." Replacing error-prone handwritten scribbles and shouts, Ultimate is a digital workflow solution, connecting the front- and back-of-the house directly with diners and creating a transparent view into their order status - whether diners order for pickup or delivery on Grubhub, at an in-store kiosk, or directly with a cashier.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Noble Midstream raises quarterly dividend to 68.8c from 67.2c per share » 18:16
01/23/20
01/23
18:16
01/23/20
18:16
NBLX

Noble Midstream

$23.40 /

-0.75 (-3.11%)

The dividend will be…

The dividend will be payable on February 14, 2020 to unitholders of record as of February 4, 2019.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
SPDR Gold Shares holdings rise to 900.58MT from 898.82MT » 18:14
01/23/20
01/23
18:14
01/23/20
18:14
GLD

SPDR Gold Shares

$147.11 /

+0.33 (+0.22%)

This is the highest level…

This is the highest level of holdings since November 11th.

Periodicals
Sonos CEO apologizes for perceived 'planned obsolescence' move, Verge reports » 18:04
01/23/20
01/23
18:04
01/23/20
18:04
SONO

Sonos

$14.35 /

-0.115 (-0.80%)

Chris Welch of the Verge…

Chris Welch of the Verge writes that Sonos CEO Patrick Spence tried to "clear up an announcement" from earlier this week that stated the company will "cease delivering software updates and new features to its oldest products in May." Amid criticisms that the company was instigating a planned obsolescence, Sonos CEO Patrick Spence apologized "for any confusion" and reassured the company's customers "that the so-called legacy products," including the original Sonos Play:5, Zone Players, and Connect / Connect:Amp will "continue to work as they do today," according to the Verge story. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Carlyle's Rubenstein says eyeing 'relatively cheap' energy assets, Reuters says » 17:58
01/23/20
01/23
17:58
01/23/20
17:58
CG

Carlyle Group

$34.52 /

+0.24 (+0.70%)

Carlyle founder and…

Carlyle founder and co-executive chairman David Rubenstein said that worries about the future of energy assets have led to a selloff, but this has created "very good opportunities" for the private equity firm, Reuters' Divya Chowdhury and Aaron Saldanha report. Rubenstein told the Reuters Global Markets Forum that securing bank loans for such deals, however, have become more difficult. "Right now, energy is relatively cheap and therefore we are looking at lot of assets where there has been a sell-off in the value, in part because people are nervous about the future of carbon energy," he said. "So we still think there are very good opportunities there." Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Insys founder sentenced to 66 months in prison over bribery scheme, Reuters says » 17:56
01/23/20
01/23
17:56
01/23/20
17:56
INSY

Insys Therapeutics

$0.00 /

+ (+0.00%)

Insys Therapeutics…

Insys Therapeutics founder John Kapoor has been sentenced to 66 months in prison for his role in a bribery and fraud scheme that ultimately played a role in the U.S. opioid crisis, Reuters' Tim McLaughlin reports. Kapoor is now the highest-ranking pharmaceutical executive to be sentenced in a case connected to the drug crisis, McLaughlin says. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Uber expects to begin operating in Vancouver soon, Bloomberg says » 17:52
01/23/20
01/23
17:52
01/23/20
17:52
UBER

Uber

$37.40 /

+0.33 (+0.89%)

Uber will finally start…

Uber will finally start operating in Vancouver, British Columbia, Bloomberg's Gerrit De Vynck reports. Vancouver was originally one of the ride-hailing giant's first targeted destinations outside of the U.S., but provincial authorities quickly rebuffed them, De Vynck notes. "We received authorization from the passenger transportation board to provide service across Metro Vancouver," Michael van Hemmen, an Uber spokesman, said at a press conference. "We expect to be available in the next few days." Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.